9-aminocamptothecin has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boothman, DA; Kinsella, TJ; Lamond, JP; Wang, M | 1 |
1 review(s) available for 9-aminocamptothecin and Malignant Melanoma
| Article | Year |
|---|---|
Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors.
Topics: Antineoplastic Agents; Camptothecin; Cell Survival; DNA Topoisomerases, Type I; Dose-Response Relationship, Radiation; Humans; Melanoma; Radiation Tolerance; Time Factors; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1996 |